Congrats to GW licensee, La Jolla Pharmaceuticals for achieving top-line results in phase III clinical trial!

Congrats to GW licensee, La Jolla Pharmaceuticals for achieving top-line results in phase III clinical trial!

March 02, 2017
 GW Licensee, La Jolla Pharmaceuticals, Achieves Positive Top Line Results in Phase III Clinical Trial for Hypotension Treatment in Shock Patients.